It also makes precise, independent dosage adjustments impossible
Routes of Administration Subcutaneous injection (standard): Protocols describe injection in the abdomen, thigh, or upper arm, rotating sites between injections, using standard SC technique with a 29-31 gauge insulin syringe
First few months: This is typically the active titration phase - providers adjusting the dose based on tolerance and response, GI side effects (when present) often diminishing, and more visible weight changes becoming apparent for patients who respond to treatment
This, combined with potential vomiting or diarrhea from GLP-1 agonists, can increase the risk of dehydration
References Regulatory, Clinical, and Analytical Sources For instance, DailyMed
Both GLP-1 receptor agonists and metformin are commonly used to manage insulin resistance , but they work in different ways